Nutrient sachets may boost vaccination rates in rural africa
NCT ID NCT07592260
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study in Chad and Niger tests whether giving a small, nutrient-packed food supplement (SQ-LNS) to children aged 6 to 11 months can encourage families to complete routine vaccinations. Around 20,000 children will receive the supplement until they are 18 months old, and researchers will compare vaccination rates to areas without the program. The goal is to break the cycle of malnutrition and infectious disease by improving both nutrition and immunization coverage.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- small quantity lipid-based nutritional supplement (SQ-LNS)
- What this could lead to
- If successful, this approach could provide a simple, low-cost way to boost childhood vaccination coverage and reduce severe malnutrition in vulnerable communities.
- What could go wrong
- This is a large but early-stage field study; real-world challenges like supply chains, community acceptance, and measuring true vaccination impact may limit results.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 20,000 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
May 2025
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
6 to 59 months
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * All non-malnourished children between 6 and 12 months of age will be eligible for SQ-LNS supplementation until they reach 18 months of age. For the annual household surveys, * Children aged 6 to 59 months will be surveyed on MUAC status and other malnutrition-related issues, while the immunization analysis will focus on children aged 12 to 23 months; * With the informed oral consent of the parents or legal guardian ; * Reside in the neighborhoods included in the study. For the mixed-methods process evaluation and gender sub-study (to be carried out in the months following implementation). Inclusion criteria * OptiMAx intervention personnel (e.g. healthcare staff) * A group of mothers of children benefiting from the intervention * Male partners/spouses of parents * Community members from the sites targeted by the intervention will be recruited for the focus groups. * Non-adherents or parents who choose not to continue nutritional supplementation and/or vaccination despite their availability under the program will be recruited for interviews. * Husbands/male partners of non-members will also be surveyed. Exclusion Criteria: * Age-eligible children with MUAC \<125 or edema will first be treated for acute malnutrition with OptiMA and then resume supplementation with SQ-LNS. There is no exclusion criteria for the annual household surveys Exclusion criteria for the mixed-methods process evaluation \- Parents or guardians under 15 years of age.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Malnutrition severe are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
2 sites in 2 countries. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Mirriah hospital
RECRUITINGMirriah, Zinder Region, 70004, Niger
-
Ngouri hospital
RECRUITINGNgouri, Lac Region, 00000, Chad
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Cold and vibration may replace numbing cream for Kids' shots
- A nudge in the mailbox: could a letter boost flu shots for millions at risk?
- Seeing germs up close: a microscope workshop aims to boost vaccination and hygiene
- 3D infrared scans may reveal hidden malnutrition in anorexia — a study puts the idea to the test
- Hospital push could shield seniors from preventable diseases
- Meningitis b vaccine shows promise in children